Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
hepatitis B
Biotech
Roche drops midphase hepatitis B and eye disease programs
Roche has taken the scissors to its pipeline, snipping off phase 2 studies of potential treatments for hepatitis B virus and geographic atrophy.
Nick Paul Taylor
Oct 18, 2022 5:55am
Functional cure setback triggers layoffs at Assembly
Jul 21, 2022 9:14am
Antios hep B drug slows viral rebound, but FDA hold casts shadow
Jun 27, 2022 11:41am
GSK talks up hep B functional cure after posting phase 2 data
Jun 27, 2022 5:29am
Antios rocked as hepatitis B safety signal sparks clinical hold
May 25, 2022 8:42am
Finch's nest thins out: 20% of employees cut in restructuring
Apr 19, 2022 10:44am